Table: Hisamitsu -2024/25 parent results
Apr 10 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Feb 28, 2025 Feb 29, 2024 Feb 28, 2026 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 102.62 96.65
(+6.2 pct) (+3.9 pct)
Operating 13.71 10.70
(+28.1 pct) (-1.3 pct)
Recurring 16.51 14.23
(+16.1 pct) (+1.2 pct)
Net 16.36 9.86
(+66.0 pct) (-5.4 pct)
EPS 222.20 yen 128.08 yen
EPS Diluted 221.88 yen 127.93 yen
Ann Div 90.00 yen 85.00 yen 120.00 yen
-Q2 Div 45.00 yen 42.50 yen 60.00 yen
-Q4 Div 45.00 yen 42.50 yen 60.00 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO